Skip to main content
Erschienen in: Inflammation Research 2/2016

01.02.2016 | Original Research Paper

Midkine in vitamin D deficiency and its association with anti-Saccharomyces cerevisiae antibodies

verfasst von: F. B. Serinkan Cinemre, Hakan Cinemre, Cengiz Karacaer, Birsen Aydemir, Ahmet Nalbant, Tezcan Kaya, Ali Tamer

Erschienen in: Inflammation Research | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives and design

The growth factor midkine (MK) is a protein that is involved in cancer, inflammation, immunity. Vitamin D is a potent immunomodulator. Anti-Saccharomyces cerevisiae antibody (ASCA) is reported in autoimmune disorders, some of which are among the causes of vitamin D deficiency. The objective of this study was to investigate a possible association of MK and ASCA with vitamin D deficiency.

Materials and methods

208 adults presented to internal medicine outpatient clinic for history and physical examination has been studied. Serum biochemistry, vitamin D, MK, ASCA-IgG and -IgA, IL-1β, IL-6, IL-8, TNF-α, PDGF, VEGF were obtained.

Results

Vitamin D deficiency was 74.2 %. Serum MK level was significantly higher in vitamin D-deficient compared to vitamin D-sufficient individuals (1138.1 ± 262.8 vs 958.6 ± 189 pg/mL, respectively; P < 0.009). Serum MK levels were also significantly higher in both ASCA-IgG and -IgA positives compared to negatives (1318.5 ± 160.3 vs 1065.5 ± 256.1, P = 0.008 and 1347.7 ± 229.7 vs 1070.1 ± 250.9 pg/mL, P = 0.011, respectively). Vitamin D was significantly lower in ASCA positives (P = 0.044).Vitamin D showed positive correlation with IL-1β (r 0.338, P < 0.009) and negative correlation with VEGF (r −0.366, P < 0.004).

Conclusions

MK was significantly elevated in vitamin D deficiency and associated with ASCA positivity which was significantly increased in vitamin D deficiency. These findings suggested that molecular mechanism of vitamin D deficiency may be related with some inflammatory processes.
Literatur
1.
Zurück zum Zitat Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988;151(3):1312–8.PubMedCrossRef Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988;151(3):1312–8.PubMedCrossRef
2.
Zurück zum Zitat Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res. 1995;86:655–61.PubMedCrossRef Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res. 1995;86:655–61.PubMedCrossRef
3.
Zurück zum Zitat Garver RI Jr, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell MolBiol. 1993;9(5):463–6.CrossRef Garver RI Jr, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell MolBiol. 1993;9(5):463–6.CrossRef
4.
Zurück zum Zitat Jones DR. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol. 2014;177(12):2925–39.CrossRef Jones DR. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol. 2014;177(12):2925–39.CrossRef
5.
Zurück zum Zitat Kadomatsu K, Kishida S, Tsubota S. The heparin-binding growth factor midkine: the biological activities and candidate receptors. J Biochem. 2013;153(6):511–21.PubMedCrossRef Kadomatsu K, Kishida S, Tsubota S. The heparin-binding growth factor midkine: the biological activities and candidate receptors. J Biochem. 2013;153(6):511–21.PubMedCrossRef
9.
Zurück zum Zitat Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M, Muramatsu T, Kadomatsu K. Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J BiolChem. 2001;276:15868–75. Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M, Muramatsu T, Kadomatsu K. Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J BiolChem. 2001;276:15868–75.
10.
Zurück zum Zitat Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. Scientific World J. 2011;11:2491–505.CrossRef Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. Scientific World J. 2011;11:2491–505.CrossRef
11.
Zurück zum Zitat Muramatsu T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:410–25.PubMedPubMedCentralCrossRef Muramatsu T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:410–25.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem. 1997;122:453–8.PubMedCrossRef Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem. 1997;122:453–8.PubMedCrossRef
13.
Zurück zum Zitat Kato K, Kosugi T, Sato W, Arata-Kawai H, Ozaki T, Tsuboi N, Ito I, Tawada H, Yuzawa Y, Matsuo S, et al. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol. 2006;168(1):9–19.CrossRef Kato K, Kosugi T, Sato W, Arata-Kawai H, Ozaki T, Tsuboi N, Ito I, Tawada H, Yuzawa Y, Matsuo S, et al. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol. 2006;168(1):9–19.CrossRef
14.
Zurück zum Zitat Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg. 2006;44(3):633–41.PubMedCrossRef Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg. 2006;44(3):633–41.PubMedCrossRef
15.
Zurück zum Zitat Narita H, Chen S, Komori K, Kadomatsu K. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits. J Vasc Surg. 2008;47(6):1322–9.PubMedCrossRef Narita H, Chen S, Komori K, Kadomatsu K. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits. J Vasc Surg. 2008;47(6):1322–9.PubMedCrossRef
16.
Zurück zum Zitat Liu X, Mashour GA, Webster HD, Kurtz A. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. GLIA. 1998;20(4):390–7.CrossRef Liu X, Mashour GA, Webster HD, Kurtz A. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. GLIA. 1998;20(4):390–7.CrossRef
17.
Zurück zum Zitat Krzystek-Korpacka M, Neubauer K, Matusiewicz M. Circulating midkine in Crohn’s Disease: clinical implications. Inflamm Bowel Dis. 2010;16(2):208–15.PubMedCrossRef Krzystek-Korpacka M, Neubauer K, Matusiewicz M. Circulating midkine in Crohn’s Disease: clinical implications. Inflamm Bowel Dis. 2010;16(2):208–15.PubMedCrossRef
18.
Zurück zum Zitat Yuki T, Ishihara S, Rumi MA, Ortega-Cava CF, Kadowaki Y, Kazumori H, Ishimura N, Amano Y, Moriyama N, Kinoshita Y. Increased expression of midkine in the rat colon during healing of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;291(4):G735–43.PubMedCrossRef Yuki T, Ishihara S, Rumi MA, Ortega-Cava CF, Kadowaki Y, Kazumori H, Ishimura N, Amano Y, Moriyama N, Kinoshita Y. Increased expression of midkine in the rat colon during healing of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;291(4):G735–43.PubMedCrossRef
19.
Zurück zum Zitat Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6S.PubMed Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6S.PubMed
21.
Zurück zum Zitat Van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–80.PubMedCrossRef Van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–80.PubMedCrossRef
22.
Zurück zum Zitat Blicher TM, Jørgensen HL, Schwarz P, Wulf HC. Low levels of vitamin D are associated with increased mortality in patients attending a University hospital in Denmark. Scand J Clin Lab Invest. 2013;73(1):24–8.PubMedCrossRef Blicher TM, Jørgensen HL, Schwarz P, Wulf HC. Low levels of vitamin D are associated with increased mortality in patients attending a University hospital in Denmark. Scand J Clin Lab Invest. 2013;73(1):24–8.PubMedCrossRef
23.
Zurück zum Zitat Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963–8.PubMedCrossRef Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963–8.PubMedCrossRef
24.
Zurück zum Zitat Sun X, Cao ZB, Zhang Y, Ishimi Y, Tabata I, Higuchi M. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients. 2014;6(1):221–30.PubMedPubMedCentralCrossRef Sun X, Cao ZB, Zhang Y, Ishimi Y, Tabata I, Higuchi M. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients. 2014;6(1):221–30.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells. J BiolChem. 1989;264(31):18407–13. Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells. J BiolChem. 1989;264(31):18407–13.
27.
Zurück zum Zitat Halder SK, Osteen KG, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Repro. 2013;89(5):150.CrossRef Halder SK, Osteen KG, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Repro. 2013;89(5):150.CrossRef
28.
Zurück zum Zitat Nakanishi T, Kadomatsu K, Okamoto T, Ichihara-Tanaka K, Kojima T, Saito H, Tomoda Y, Muramatsu T. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem. 1997;121:197–205.PubMed Nakanishi T, Kadomatsu K, Okamoto T, Ichihara-Tanaka K, Kojima T, Saito H, Tomoda Y, Muramatsu T. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem. 1997;121:197–205.PubMed
29.
Zurück zum Zitat Cinemre H, Bilir C, Gokosmanoglu F, Kadakal F. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction. J Investig Med. 2007;55(8):444–9.PubMedCrossRef Cinemre H, Bilir C, Gokosmanoglu F, Kadakal F. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction. J Investig Med. 2007;55(8):444–9.PubMedCrossRef
30.
Zurück zum Zitat Rinaldi M, Perricone R, Blank M, Perricone C, Shoenfeld Y. Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin Rev Allerg Immunol. 2013;45(2):152–61.CrossRef Rinaldi M, Perricone R, Blank M, Perricone C, Shoenfeld Y. Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin Rev Allerg Immunol. 2013;45(2):152–61.CrossRef
31.
Zurück zum Zitat Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol. 2011;23:519–28.PubMedPubMedCentralCrossRef Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol. 2011;23:519–28.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Lim H, Kim YU, Sun H, Lee JH, Reynolds JM, Hanabuchi S, Wu H, Teng BB, Chung Y. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity. 2014;40(1):153–65.PubMedPubMedCentralCrossRef Lim H, Kim YU, Sun H, Lee JH, Reynolds JM, Hanabuchi S, Wu H, Teng BB, Chung Y. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity. 2014;40(1):153–65.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127:89–97.PubMedCrossRef Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127:89–97.PubMedCrossRef
34.
Zurück zum Zitat Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Trained innate immunity and atherosclerosis. Curr Opin Lipidol. 2013;24(6):487–92.PubMedCrossRef Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Trained innate immunity and atherosclerosis. Curr Opin Lipidol. 2013;24(6):487–92.PubMedCrossRef
36.
Zurück zum Zitat Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54(9):1232–6.PubMedPubMedCentralCrossRef Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54(9):1232–6.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat da Silva Kotze LM, Nisihara RM, Nass FR, Theiss PM, Silva IG, da Rosa Utiyama SR. Anti-Saccharomyces cerevisiae antibodies in first-degree relatives of celiac disease patients. J Clin Gastroenterol. 2010;44(4):308.PubMedCrossRef da Silva Kotze LM, Nisihara RM, Nass FR, Theiss PM, Silva IG, da Rosa Utiyama SR. Anti-Saccharomyces cerevisiae antibodies in first-degree relatives of celiac disease patients. J Clin Gastroenterol. 2010;44(4):308.PubMedCrossRef
38.
Zurück zum Zitat Mouli VP, Ananthakrishnan AN. Vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39(2):125–36.PubMedCrossRef Mouli VP, Ananthakrishnan AN. Vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39(2):125–36.PubMedCrossRef
39.
Zurück zum Zitat Heaney RP. What is vitamin D insufficiency and does it matter? Calcif Tissue Int. 2013;92(2):177–83.PubMedCrossRef Heaney RP. What is vitamin D insufficiency and does it matter? Calcif Tissue Int. 2013;92(2):177–83.PubMedCrossRef
40.
Zurück zum Zitat O’Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996;56(11):2515–8.PubMed O’Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996;56(11):2515–8.PubMed
41.
Zurück zum Zitat Krzystek-Korpacka M, Diakowska D, Neubauer K, Gamian A. Circulating midkine in malignant and non-malignant colorectal diseases. Cytokine. 2013;64(11):158–64.PubMedCrossRef Krzystek-Korpacka M, Diakowska D, Neubauer K, Gamian A. Circulating midkine in malignant and non-malignant colorectal diseases. Cytokine. 2013;64(11):158–64.PubMedCrossRef
42.
Zurück zum Zitat Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012;1(1):49–55.PubMedPubMedCentral Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012;1(1):49–55.PubMedPubMedCentral
43.
Zurück zum Zitat Müller S, Schaffer T, Flogerzi B, Seibold-Schmid B, Schnider J, Takahashi K, Darfeuille-Michaud A, Vazeille E, Schoepfer AM, Seibold F. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut. 2010;59(11):1493–500.PubMedCrossRef Müller S, Schaffer T, Flogerzi B, Seibold-Schmid B, Schnider J, Takahashi K, Darfeuille-Michaud A, Vazeille E, Schoepfer AM, Seibold F. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut. 2010;59(11):1493–500.PubMedCrossRef
44.
45.
Zurück zum Zitat Zanetti M, Harris SS, Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr Rev. 2014;72(2):95–8.PubMedCrossRef Zanetti M, Harris SS, Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr Rev. 2014;72(2):95–8.PubMedCrossRef
46.
Zurück zum Zitat Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn’s Disease? Eur J Gastroenterol Hepatol. 2003;15(12):1281–5.PubMedCrossRef Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn’s Disease? Eur J Gastroenterol Hepatol. 2003;15(12):1281–5.PubMedCrossRef
47.
Zurück zum Zitat Mouli VP, Ananthakrishnan AN. IBD serological panels: facts and perspectives. Inflamm Bowel Dis. 2007;13(12):1561–6.CrossRef Mouli VP, Ananthakrishnan AN. IBD serological panels: facts and perspectives. Inflamm Bowel Dis. 2007;13(12):1561–6.CrossRef
48.
Zurück zum Zitat Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H, et al. Clinical characteristics of inflammatory bowel disease: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43(1):51–7.PubMedCrossRef Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H, et al. Clinical characteristics of inflammatory bowel disease: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43(1):51–7.PubMedCrossRef
49.
Zurück zum Zitat Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut. 2006;55:296.PubMedPubMedCentral Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut. 2006;55:296.PubMedPubMedCentral
Metadaten
Titel
Midkine in vitamin D deficiency and its association with anti-Saccharomyces cerevisiae antibodies
verfasst von
F. B. Serinkan Cinemre
Hakan Cinemre
Cengiz Karacaer
Birsen Aydemir
Ahmet Nalbant
Tezcan Kaya
Ali Tamer
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 2/2016
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0898-6

Weitere Artikel der Ausgabe 2/2016

Inflammation Research 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir nicht substanzbedingt Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.